Navigation Links
Lilly Diabetes and Disney Publishing Worldwide Expand Collaboration

INDIANAPOLIS, April 30, 2013 /PRNewswire/ --

News Highlights:

  • Lilly Diabetes expands collaboration with Disney Publishing Worldwide globally.
  • New educational resources will be available soon for families of children with type 1 diabetes.

Lilly Diabetes today announced the global expansion of its innovative collaboration with Disney Publishing Worldwide (DPW), which expands the program internationally based on the success of the initiative in the U.S., which began in 2011. The goal of the program is to bring thoughtful educational resources to families of children with diabetes, including a series of custom books co-created by Lilly Diabetes and DPW for children of various ages and stages of life who are living with type 1 diabetes. The books, available through diabetes healthcare professionals, will initially be translated and available in 18 countries.

"Lilly Diabetes' objective is to bring safety, health, comfort and a bit of magic to children worldwide," said Andrew Hodge , vice president, International, Lilly Diabetes. "We saw the positive impact our collaboration with Disney Publishing Worldwide had on families living with type 1 diabetes in the U.S. over the last two years, and we are excited to expand our reach globally."

Nearly 500,000 young people worldwide are living with type 1 diabetes, and an estimated 78,000 are diagnosed each year.[1] From the moment of diagnosis to the day-in, day-out management of the disease, the challenges of living with the disease can be overwhelming for children and their families. People with type 1 diabetes must follow a structured self-management regimen that includes a balance of medication, physical activity and a healthy diet.[1]

By expanding this collaboration, Lilly Diabetes and DPW hope to reach even more families who have been impacted by type 1 diabetes – emphasizing what they can do instead of what they can't do, and offering stories of familiar characters, such as Mickey Mouse and his friend Coco, the fun-loving monkey who has type 1 diabetes.

"We are excited to be part of this effort to bring informational material about type 1 diabetes to kids around the world who are living with the disease," said Andrew Sugerman , executive vice president, DPW. "Lilly Diabetes' expertise with the disease, combined with Disney's tradition of great storytelling, gives us an opportunity to inspire and motivate children and families with type 1 diabetes."

About Disney Publishing Worldwide
Disney Publishing Worldwide (DPW) is the world's largest publisher of children's books and magazines with over 700 million products sold each year. Disney Publishing Worldwide consists of an extensive worldwide licensing structure as well as vertically integrated publishing imprints, including Disney Book Group in the U.S., Disney Libri in Italy, and Disney Libros in Spain. DPW publishes a range of children's magazines globally, including Topolino, Le Journal de Mickey, and Donald Duck , as well as Disney kids magazines in the U.S., which include Disney Princess and Phineas and Ferb. Disney English is DPW's English language learning business, which includes Disney English learning centers in China and a worldwide retail licensing program. DPW's digital products include bestselling eBook titles as well as original apps. Headquartered in Glendale, California, Disney Publishing Worldwide publishes books, magazines, and digital products in 85 countries in 75 languages. For more information visit

About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and a continued commitment to providing real solutions—from medicines to support programs and more—to make lives better. For more information, visit

About Eli Lilly and Company (NYSE: LLY)
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers—through medicines and information—for some of the world's most urgent medical needs. Information about Lilly is available at


LD81967 02/2013 ©Lilly USA, LLC 2013. All rights reserved.

[1] "Diabetes in the Young." Adapted from: International Diabetes Federation, IDF Diabetes Atlas. 2012. Available at: Accessed 28 November 2012.

(Logo: )
(Logo: )
(Logo: )

Refer to: +1 (317) 627-4056 – Julie Williams , Lilly Diabetes

SOURCE Eli Lilly and Company; Disney Publishing Worldwide
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams
2. Lilly Again Named One of DiversityIncs Top 50 Companies for Diversity
3. Lilly Reports First-Quarter 2013 Results
4. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
5. Lilly Confirms Date and Conference Call for First-Quarter 2013 Financial Results Announcement
6. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
7. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
8. Lilly Sets Date for 2013 Diabetes Pipeline Update to the Media and Investment Community
9. StockCall Insight into Eli Lilly, Bristol-Myers Squibb, Astex Pharmaceuticals and Raptor Pharmaceuticals
10. Lillys Team Solutions and Solutions for Wellness Resources for Serious Mental Illness Added to SAMHSAs Distinguished National Registry
11. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
Post Your Comments:
(Date:12/1/2015)... 1, 2015   MabVax Therapeutics Holdings, Inc . ... it has filed an Investigational New Drug Application (IND) ... the Company,s lead fully human antibody product HuMab 5B1 ... plans to initiate the Phase I clinical trial early ... --> The planned Phase I trial will evaluate ...
(Date:12/1/2015)... , Dec. 1, 2015   Craneware, Inc ... cycle solutions, today announced the company will showcase ... ChargeLink ® solution at the American ... Clinical Meeting . The new features are focused ... of monitoring and managing enterprise-wide pharmacy charges to ...
(Date:12/1/2015)... , Dec. 01, 2015 ... of the "Medical Alert Systems/Personal Emergency Response ... by Geography - Global Forecas" report to ... announced the addition of the "Medical Alert ... by End-User and by Geography - Global Forecas" ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... The Multiple System Atrophy Coalition has announced the launch of ... (MSA) research, timed today to coincide with Giving Tuesday 2015, a global day of ... to work and be productive, to do simple daily activities like walking to the ...
(Date:12/1/2015)... ME (PRWEB) , ... December 01, 2015 , ... Royal ... reports a new study that found post-menopausal women who took the nutritional supplement creatine, ... than women who trained but did not take creatine. , The report is part ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, ... expansion of the company’s growing product line of food safety and seafood fraud ... Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic ... United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a ... catastrophic contributors to diseases of the diabetic foot. The American Board of ...
Breaking Medicine News(10 mins):